Your browser doesn't support javascript.
loading
Differences in the Clinical Outcome of Ischemic and Nonischemic Cardiomyopathy in Heart Failure With Concomitant Opioid Use Disorder.
Gharbin, John; Winful, Adwoa; Hassan, Mubariz Ahmed; Bajaj, Siddharth; Batta, Yashvardhan; Alebna, Pamela; Rhodd, Suchellis; Taha, Mohammed; Fatima, Urooj; Mehrotra, Prafulla.
Afiliação
  • Gharbin J; Department of Medicine, Howard University Hospital, Washington DC, USA. Electronic address: john.gharbin@howard.edu.
  • Winful A; Department of Hospital Medicine, Doctors Hospital of Augusta, Augusta, GA, USA.
  • Hassan MA; Department of Medicine, Howard University Hospital, Washington DC, USA.
  • Bajaj S; Department of Medicine, Howard University Hospital, Washington DC, USA.
  • Batta Y; College of Medicine, Howard University, Washington, DC, USA.
  • Alebna P; Department of Medicine, RWJ Barnabas Health, Jersey City, NJ, USA.
  • Rhodd S; Division of Cardiovascular Disease, Howard University Hospital, Washington, DC, USA.
  • Taha M; Division of Cardiovascular Disease, Howard University Hospital, Washington, DC, USA.
  • Fatima U; College of Medicine, Howard University, Washington, DC, USA; Division of Cardiovascular Disease, Howard University Hospital, Washington, DC, USA.
  • Mehrotra P; College of Medicine, Howard University, Washington, DC, USA; Division of Cardiovascular Disease, Howard University Hospital, Washington, DC, USA.
Curr Probl Cardiol ; 48(5): 101609, 2023 May.
Article em En | MEDLINE | ID: mdl-36690309
ABSTRACT
Heart Failure (HF) and Opioid Use Disorder (OUD) independently have significant impact on patients and the United States (US) health system. In the setting of the opioid epidemic, research on the effects of OUD on cardiovascular diseases is rapidly evolving. However, no study exists on differential outcomes of ischemic cardiomyopathy (ICM) and nonischemic cardiomyopathy (NICM) in patients with HF with OUD. We performed a retrospective, observational cohort study using National Inpatient Sample (NIS) 2018-2020 databases. Patients aged 18 years and above with diagnoses of HF with concomitant OUD were included. Patients were further classified into ICM and NICM. Primary outcome of interest was differences in all- cause in-hospital mortality. Secondary outcome was incidence of cardiogenic shock. We identified 99,810 hospitalizations that met inclusion criteria, ICM accounted for 27%. Mean age for ICM was higher compared to NICM (63 years vs 56 years, P < 0.01). Compared to NICM, patients with ICM had higher cardiovascular disease risk factors and comorbidities; type 2 diabetes mellitus (46.3 % vs 30.1%, P < 0.01), atrial fibrillation/flutter (33.5% vs 29.9%, P < 0.01), hyperlipidemia (52.5% vs 28.9%, P < 0.01), and Charlson comorbidity index ≥5 was 46.7% versus 29.7%, P < 0.01. After controlling for covariates and potential confounders, we observed higher odds of all-cause in-hospital mortality in patients with NICM (aOR = 1.36; 95% CI1.03-1.78, P = 0.02). There was no statistical significant difference in incidence of cardiogenic shock between ICM and NICM (aOR = 0.86;95% CI 0.70-1.07, P = 0.18). In patients with HF with concomitant OUD, we found a 36% increase in odds of all-cause in-hospital mortality in patients with NICM compared to ICM despite being younger in age with less comorbidities. There was no difference in odds of in-hospital cardiogenic shock in this study population. This study contributes to the discussion of OUD and cardiovascular diseases which is rapidly developing and requires further prospective studies.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Isquemia Miocárdica / Diabetes Mellitus Tipo 2 / Insuficiência Cardíaca / Cardiomiopatias Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Isquemia Miocárdica / Diabetes Mellitus Tipo 2 / Insuficiência Cardíaca / Cardiomiopatias Idioma: En Ano de publicação: 2023 Tipo de documento: Article